BeiGene Ltd (ONC)
250.98
-2.22
(-0.88%)
USD |
NASDAQ |
Mar 25, 16:00
250.98
0.00 (0.00%)
After-Hours: 20:00
BeiGene Shareholders Equity (Quarterly): 3.332B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences Inc | 19.33B |
| Leap Therapeutics Inc | 48.95M |
| Catalyst Pharmaceuticals Inc | 727.63M |
| Exelixis Inc | 2.244B |
| Halozyme Therapeutics Inc | 363.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.921B |
| Total Liabilities (Quarterly) | 2.589B |
| Debt to Equity Ratio | 0.3055 |
| Current Ratio | 1.802 |
| Net Debt Paydown Yield | -0.50% |